Pandion Therapeutics

Former Merck VP Nirdosh Jagota settles with SEC on insider trading charge
Fierce Pharma
Thu, 07/20/23 - 09:58 am
Merck
Pandion Therapeutics
SEC
insider trading
Three more biotechs tumble onto Wall Street today, raising $475M as the IPO party rocks on
Endpoints
Fri, 07/17/20 - 10:52 am
IPOs
ALX Oncology
Berkeley Lights
Pandion Therapeutics
NASDAQ
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in
Endpoints
Mon, 06/29/20 - 10:34 am
IPOs
biotech
Berkeley Lights
ALX Oncology
Pandion Therapeutics
Kiromic Biopharma
Pandion Raises $80 Million Series B to Advance Autoimmune Therapies
BioSpace
Wed, 04/1/20 - 10:14 am
Pandion Therapeutics
autoimmune disease
Pandion, Astellas sign $900m deal for pancreas-targeted immunomodulators
Pharmaceutical Business Review
Thu, 10/31/19 - 11:03 am
Astellas
Pandion Therapeutics
immunomodulators
autoimmune disease
Pancreas